Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Preventing phantom limb pain from becoming chronic with mirror therapy and tDCS

Official title: Preventing Chronification of Phantom Limb Pain Through Mirror Therapy in Conjunction With Transcranial Direct Current Stimulation

Run by University of Haifa · NCT07139483 · Data updated 2026-11-12

This trial will try combining mirror therapy with transcranial direct current stimulation (tDCS) in adults who recently had a limb amputated and are experiencing early phantom limb pain to see if it prevents the pain from becoming long-term.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment108 (estimated)
SponsorUniversity of Haifa
Academic / other
Locations3 sites (Raanana, Israel and 2 other locations)
StatusRecruiting
StartedMarch 25, 2025
Main results expectedDecember 2028
Study endsMarch 2029
Registry record updatedSeptember 8, 2025
Trial IDNCT07139483 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a single limb amputation within the last 12 weeks who report acute phantom limb pain of at least 3/10 (and at least two weeks since first report), can understand the protocol, and consent are the intended participants.

Probably not a fit

People with unhealed stump wounds, prior seizures or other neurological/psychiatric contraindications, implanted devices or metal in the head, pregnancy, inability to consent, or those with longstanding chronic PLP outside the acute window are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The investigators will enroll adults with a single limb amputation within the past 12 weeks who report acute phantom limb pain and apply a combined intervention of mirror therapy and tDCS early after pain onset. Participants will receive supervised sessions of mirror-based sensorimotor training alongside noninvasive low‑current brain stimulation aimed at modulating cortical excitability. The protocol targets the acute phase of PLP to try to prevent maladaptive neuroplastic changes that contribute to chronification. Standard inclusion/exclusion criteria limit enrollment to patients with healed stumps and without neurological, psychiatric, or device-related contraindications.

Why it matters

Potential benefit: If successful, the combined approach could reduce the chance that early phantom limb pain becomes chronic and lower the need for long-term pain medications.

How similar studies have gone: Mirror therapy has shown benefit in some patients with chronic PLP and tDCS alone yields mild, short-lived analgesia, but applying the two together in the acute post-amputation phase is a novel approach with limited prior data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (age ≥18);
* Amputation of a single limb ≤12 weeks ago; during this period of time, 80% of amputees develop PLP. Both upper and lower limb amputees are included to increase feasibility;
* Acute PLP stage (2 weeks since first report), with intensity ≥3 on a 0-10 VAS;
* No change in medication in past week, excluding pro re nata analgesics;
* Can understand the study's purpose and instructions;
* Agrees to participate and to provide written informed consent.

Exclusion Criteria:

* Stump wound not healed;
* Other psychological, psychiatric, or neurological conditions;
* Contraindications for tDCS or magnetic resonance imaging (MRI) (MRI data will not be analyzed in the proposed PhD project), including previous seizure, loss of consciousness due to head injury, metal in the head, implanted devices, claustrophobia, a skin condition or an unhealed wound on the scalp, and possibility of being pregnant;
* Inability to provide informed consent or understand or carry out the experiment.

Where it's running

  • Loewenstein Hospital
    Raanana, Israel, Israel
    Recruiting
  • Reut Medical Center
    Tel Aviv, Israel, Israel
    Recruiting
  • Sheba Medical Center
    Tel Aviv, Israel
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.